RVL Pharmaceuticals (FRA:O1P) Other Gross PPE : €3.51 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Other Gross PPE?

RVL Pharmaceuticals's Other Gross PPE for the quarter that ended in Jun. 2023 was €3.51 Mil.

RVL Pharmaceuticals's quarterly Other Gross PPE increased from Dec. 2022 (€0.85 Mil) to Mar. 2023 (€2.81 Mil) and increased from Mar. 2023 (€2.81 Mil) to Jun. 2023 (€3.51 Mil).

RVL Pharmaceuticals's annual Other Gross PPE declined from Dec. 2020 (€3.43 Mil) to Dec. 2021 (€2.21 Mil) and declined from Dec. 2021 (€2.21 Mil) to Dec. 2022 (€0.85 Mil).

RVL Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for RVL Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Other Gross PPE Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Gross PPE

Get a 7-Day Free Trial

1.86

7.57

3.43

2.21

0.85

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Gross PPE	Get a 7-Day Free Trial															1.50	1.40	0.85	2.81	3.51

RVL Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines